Difference between revisions of "Perseus LLC"

From SourceWatch
Jump to navigation Jump to search
m (SW: add full ref)
m (SW: fmt tweak)
Line 1: Line 1:
'''Perseus LLC''' (''Perseus'') is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from [[venture capital]] financings to [[leveraged buyout]]s and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."<ref>Perseus LLC, [http://207.19.194.179/intro.htm "Introduction"], October 10, 2007.</ref>
+
'''Perseus LLC''' (''Perseus'') is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from [[venture capital]] financings to leveraged buyouts and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."<ref>Perseus LLC, [http://207.19.194.179/intro.htm "Introduction"], October 10, 2007.</ref>
  
 
Perseus and its affiliates manage five investment funds:
 
Perseus and its affiliates manage five investment funds:
Line 9: Line 9:
 
*Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund")
 
*Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund")
  
== Leadership ==
+
== Principals ==
  
 
*[[Frank H. Pearl]], Chairman and Chief Executive Officer  
 
*[[Frank H. Pearl]], Chairman and Chief Executive Officer  
*[[Richard Charles Albert Holbrooke]], Vice Chairman
+
*[[Richard Charles Albert Holbrooke|Richard Holbrooke]], Vice Chairman
 
*[[James A. Johnson]], Vice Chairman
 
*[[James A. Johnson]], Vice Chairman
 
 
*[http://207.19.194.179/bios.htm#top Other Perseus Biographies]
 
 
*[[Lewis A. Lee Sachs]], Vice Chairman
 
*[[Lewis A. Lee Sachs]], Vice Chairman
 
*[[John T. Schwieters]], Vice Chairman
 
*[[John T. Schwieters]], Vice Chairman
Line 35: Line 32:
  
 
==Contact details==
 
==Contact details==
2099 Pennsylvania Avenue, N.W., 9th Floor<br>
+
:2099 Pennsylvania Avenue, N.W., 9th Floor
Washington, D.C. 20006<br>
+
:Washington, D.C. 20006
Phone: (202) 452-0101<br>
+
:Phone: (202) 452-0101
Fax: (202) 429-0588<br>
+
:Email: info AT perseusllc.com
Email: info AT perseusllc.com<br>
+
:Web: http://perseusllc.com/intro.htm
Web: http://perseusllc.com/intro.htm<br>
 
  
1325 Avenue of the Americas, 25th Floor<br>
+
:1325 Avenue of the Americas, 25th Floor
New York, NY 10019<br>
+
:New York, NY 10019
Phone: (212) 651-6400<br>
+
:Phone: (212) 651-6400
Fax: (212) 651-6399<br>
 
  
 
==Article and Resources==
 
==Article and Resources==

Revision as of 20:32, 17 February 2012

Perseus LLC (Perseus) is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from venture capital financings to leveraged buyouts and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."[1]

Perseus and its affiliates manage five investment funds:

  • Perseus 1996
  • Perseus Capital, L.L.C. ("Perseus Capital")
  • Perseus 2000, L.L.C. ("Perseus 2000")
  • Perseus Acquisition/Recapitalization Fund, L.L.C. (the "Acquisition/Recap Fund")
  • Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund")

Principals

Contact details

2099 Pennsylvania Avenue, N.W., 9th Floor
Washington, D.C. 20006
Phone: (202) 452-0101
Email: info AT perseusllc.com
Web: http://perseusllc.com/intro.htm
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
Phone: (212) 651-6400

Article and Resources

Sources

  1. Perseus LLC, "Introduction", October 10, 2007.

Related SourceWatch articles

External links